Reactional changes in short-term levonorgestrel-releasing intrauterine system (lng-ius) use

被引:3
|
作者
Giraldo, Paulo Cesar [1 ]
de Souza, Thais Coelho [1 ]
Henrique, Guilherme Lindman [1 ]
Monteiro, Ilza [1 ]
Amaral, Rose [1 ]
Machado, Rogerio Bonassi [2 ]
Discacciati, Michelle Garcia [1 ]
Sanches, Jose Marcos [1 ]
机构
[1] Univ Estadual Campinas, UNICAMP, Dept Gynecol & Obstet, Rua Alexandre Fleming 101, BR-13083880 Campinas, SP, Brazil
[2] Sch Med Jundiai, Dept Obstet & Gynecol, Jundiai, SP, Brazil
来源
关键词
Levonorgestrel/adverse effects; Contraceptive Agents/adverse effects; Vaginosis; bacterial; Vaginal discharge; BACTERIAL VAGINOSIS; VAGINAL FLORA; GRAM STAIN; WOMEN; CONTRACEPTIVES; CELLS;
D O I
10.1590/1806-9282.65.6.857
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE: To evaluate endocervical and vaginal environment changes in women using a levonorgestrel-releasing intrauterine system (LNG-IUS). METHODS:A quasi-experimental study included sixty women who had an LNG-IUS inserted in the Family Planning Clinic of UNICAMP between April and November of 2016. Women in reproductive age, non-pregnant, without the use of antibiotics and contraceptives seeking for LNG-IUS insertion were selected for this study. All women were evaluated with regard to vaginal and endocervical pH, vaginal and endocervical Gram-stained bacterioscopy, and Pap-smear before and two months after LNG-IUS insertion. Clinical aspects such as cervical mucus, vaginal discharge, and cervical ectopy were also observed. RESULTS: After LNG-IUS insertion, there was an increase in the following parameters: endocervical pH>4.5 (p=0.02), endocervical neutrophil amount (p<0.0001), vaginal cytolysis (p=0.04). There was a decrease in vaginal discharge (p=0.01). No statistically significant changes were found in vaginal pH, neutrophils amount in the vaginal mucosa, vaginal discharge appearance, vaginal candidiasis, bacterial vaginosis, vaginal coccobacillary microbiota, cervical mucus appearance, or cervical ectopy size. CONCLUSIONS: Short-term LNG-IUS use did not increase vulvovaginal candidiasis or bacterial vaginosis, and led to diminished vaginal discharge. Notwithstanding, this device promoted reactional changes in the vaginal and endocervical environment, without modification on cervical ectopy size.
引用
收藏
页码:857 / 863
页数:7
相关论文
共 50 条
  • [11] Usage of the levonorgestrel-releasing intrauterine system (LNG-IUS) in adolescence: what is the evidence so far?
    Patseadou, Magdalini
    Michala, Lina
    [J]. ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2017, 295 (03) : 529 - 541
  • [12] Usage of the levonorgestrel-releasing intrauterine system (LNG-IUS) in adolescence: what is the evidence so far?
    Magdalini Patseadou
    Lina Michala
    [J]. Archives of Gynecology and Obstetrics, 2017, 295 : 529 - 541
  • [13] Bleeding Pattern and Safety of Consecutive Use of the Levonorgestrel-Releasing Intrauterine System (LNG-IUS)-A Multicentre Prospective Study
    Gemzell-Danielsson, K.
    Inki, P.
    Boubli, L.
    O'Flynn, M.
    Kunz, M.
    Heikinheimo, O.
    [J]. OBSTETRICAL & GYNECOLOGICAL SURVEY, 2010, 65 (06) : 385 - 386
  • [14] Bleeding pattern and safety of consecutive use of the levonorgestrel-releasing intrauterine system (LNG-IUS)-a multicentre prospective study
    Gemzell-Danielsson, K.
    Inki, P.
    Boubli, L.
    O'Flynn, M.
    Kunz, M.
    Heikinheimo, O.
    [J]. HUMAN REPRODUCTION, 2010, 25 (02) : 354 - 359
  • [15] Cytological evaluation and investigation of the vaginal flora of long-term users of the levonorgestrel-releasing intrauterine system (LNG-IUS)
    Lessard, Tricia
    Simoes, Jose A.
    Discacciati, Michelle G.
    Hidalgo, Margarete
    Bahamondes, Luis
    [J]. CONTRACEPTION, 2008, 77 (01) : 30 - 33
  • [16] Suspected Levonorgestrel-Releasing Intrauterine System (LNG-IUS)-Induced Secondary Adrenal Insufficiency: A Case Report
    Joseph, Anthony T.
    Corrigan, William
    Asghar, Shoaib
    Abanilla, Fernando
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (08)
  • [17] Cost-effectiveness analysis of levonorgestrel-releasing intrauterine system (LNG-IUS) 13.5 mg in contraception
    Trussell, James
    Hassan, Fareen
    Henry, Nathaniel
    Pocoski, Jennifer
    Law, Amy
    Filonenko, Anna
    [J]. CONTRACEPTION, 2014, 89 (05) : 451 - 459
  • [18] FFPRHC Guidance (April 2004) The levonorgestrel-releasing intrauterine system (LNG-IUS) in contraception and reproductive health
    不详
    [J]. JOURNAL OF FAMILY PLANNING AND REPRODUCTIVE HEALTH CARE, 2004, 30 (02): : 99 - 108
  • [19] Disparities in uptake of levonorgestrel-releasing intrauterine system (LNG-IUS): implications for uterine cancer primary prevention
    Yeh, Paul G.
    Toumazis, Iakovos
    Sun, Charlotte
    Lu, Karen
    Meyer, Larissa A.
    [J]. CANCER RESEARCH, 2023, 83 (07)
  • [20] AN EVALUATION OF THE SIMULTANEOUS USE OF THE LEVONORGESTREL-RELEASING INTRAUTERINE SYSTEM (LNG-IUS, MIRENA®) COMBINED WITH ENDOMETRIAL ABLATION IN THE MANAGEMENT OF MENORRHAGIA
    Vaughan, D. A.
    Byrne, P.
    [J]. IRISH JOURNAL OF MEDICAL SCIENCE, 2011, 180 : 154 - 154